| Opportunity ID: |
330730 |
| Opportunity Number: |
NOT-OD-21-044 |
| Opportunity Title: |
Notice of Intent to Publish a Funding Opportunity Announcement for Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed) |
| Opportunity Category: |
Discretionary |
| Opportunity Category Explanation: |
|
| Funding Instrument Type: |
Grant |
| Category of Funding Activity: |
Health |
| Category Explanation: |
|
| CFDA Number(s): |
93.077 |
| Eligible Applicants: |
State governments
County governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: |
|
| Agency Code: |
HHS-NIH11 |
| Agency Name: |
Department of Health and Human Services
National Institutes of Health |
| Posted Date: |
Jan 05, 2021 |
| Last Updated Date: |
Jan 05, 2021 |
| Estimated Synopsis Post Date: |
Mar 08, 2021 |
| Fiscal Year: |
2022 |
| Award Ceiling: |
$275,000 |
| Award Floor: |
|
| Estimated Total Program Funding: |
$1,000,000 |
| Expected Number of Awards: |
5 |
| Description: |
This Notice is to inform the research community that the National Institutes of Health (NIH) Tobacco Regulatory Science Program (TRSP), participating NIH Institutes and Centers (ICs), and the United States Food and Drug Administration (FDA) Center for Tobacco Products (CTP) intend to reissue the Funding Opportunity Announcement (FOA) RFA-OD-19-021 "Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed)." When reissued, this FOA will continue to utilize the R21 grant mechanism. Modifications to this FOA include funding as NIH, via NIH support from the FDA Center for Tobacco Products (CTP), intends to fund up to 5 R21s, corresponding to a total of up to $1.0 million, for fiscal year 2021. Future year amounts will depend on availability of funds. This Notice is being provided to allow potential eligible applicants sufficient time to develop competitive and responsive projects. The FOA is expected to be published in Spring 2021. Details of the planned FOA are provided below. |
| Version: |
1 |
